Remus Pharmaceuticals share price
You have to be logged in to add this to Watchlist.- ₹780.00(8.18%)May 15, 2026 11:00:28 AM IST
- NSE
- BSE
- Vol : 5.40 K (NSE + BSE)Last 20 day avg : 6.16 K
Remus Pharmaceuticals is trading 8.18% upper at Rs 780.00 as compared to its last closing price. Remus Pharmaceuticals has been trading in the price range of 783.85 & 718.00. Remus Pharmaceuticals has given 2.68% in this year & -3.46% in the last 5 days. Remus Pharmaceuticals has TTM P/E ratio 23.13 as compared to the sector P/E of 31.35.The company posted a net profit of 17.50 Crores in its last quarter.Listed peers of Remus Pharmaceuticals include Divi's Laboratories (-0.24%), Sun Pharmaceutical Industries (0.98%), Lupin (0.81%).The Mutual Fund holding in Remus Pharmaceuticals was at -% in . The MF holding has - from the last quarter. The FII holding in Remus Pharmaceuticals was at 5.28% in 31 Mar 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on May 15, 2026, 05:46 AM UTC
- Debt To EquityLower than industry0.09The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.14Annual dividends as a percentage of the stock price.
- PEG RatioIndicates undervaluation0.22The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- Beta-Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | Bullish | 6,905.50 | -0.24 | 1,82,660.94 | 81.10 | 11.89 | 0.45 | 0.01 |
| Sun Pharmaceutical Industries | Bullish | 1,881.40 | 0.98 | 4,51,436.59 | 38.28 | 6.09 | 0.90 | 0.50 |
| Lupin | Neutral | 2,276.00 | 0.81 | 1,04,191.55 | 33.60 | 6.53 | 0.49 | 11.80 |
| Torrent Pharmaceuticals | Bullish | 4,397.65 | -0.26 | 1,48,542.43 | 76.60 | 19.45 | 0.80 | 17.62 |
| Cipla | Moderately Bullish | 1,433.85 | -0.33 | 1,16,199.49 | 20.90 | 3.53 | 0.95 | 0.81 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-20 | Audited Results, Dividend & Others |
| 2025-11-10 | Quarterly Results & Interim Dividend |
| 2025-05-17 | Audited Results, Dividend & Others |
| 2024-11-09 | Quarterly Results & Interim Dividend |
| 2024-05-16 | Audited Results |
- IndustryBiotechnology & Drugs
- ISININE0O5T01011
- BSE Code
- NSE CodeREMUS
Remus Pharmaceuticals is trading at 780.00 as on Fri May 15 2026 05:30:28. This is 8.18% upper as compared to its previous closing price of 721.05.
The market capitalization of Remus Pharmaceuticals is 919.15 Cr as on Fri May 15 2026 05:30:28.
The 52 wk high for Remus Pharmaceuticals is 1139.50 whereas the 52 wk low is 580.00
Remus Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 23.13
- Sector P/E: 31.35
- Dividend Yield: 0.14%
- D/E ratio: 0.05
Remus Pharmaceuticals reported a net profit of 29.07 Cr in 2025.
EQUITY QUICK LINKS
Remus Pharmaceuticals QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.